Please ensure Javascript is enabled for purposes of website accessibility

Cresco Labs Files Shelf Registration for Up to $1 Billion in Financing

By Eric Volkman - Mar 1, 2021 at 11:24PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company could sell debt securities, equity, warrants, or a combination of some or all.

Cresco Labs (CRLBF 2.49%), the ambitious multi-state operator (MSO) headquartered in Illinois, is gearing up to raise a boatload of cash. The marijuana company intends to issue up to $1 billion in new securities, it revealed in a shelf registration statement filed on Monday.

A shelf registration statement is essentially a document indicating a company's intent to float new debt, equity, or a combination of the two. In its Monday filing, Cresco wrote that it might issue one, some, or all of several different types of funding instruments, including subordinate voting shares (possibly combined with warrants) and debt securities.

Marijuana buds atop a collection of U.S. currency.

Image source: Getty Images.

Such a move has become typical for cannabis companies, as they often struggle with financial losses and cash flow drain. The most recent trend in equity fundraising is the issuance of "units," which consist of packages of stock and warrants bundled together. This theoretically makes the issue more attractive to investors than a straightforward stock flotation.

While Cresco Labs has had much success in its native state (in which recreational marijuana was legalized at the beginning of 2020), it consistently posts bottom-line losses. Meanwhile, the company aims to keep expanding its footprint throughout the U.S., and such expansion will not come cheap.

Last month, for example, it closed a deal for four new dispensaries in Ohio; it now owns the maximum five stores allowed by state law. Also in February, it was awarded a recreational marijuana license in Arizona, and since it has only one of its Sunnyside dispensaries in the state it's surely eager to build out its network there.

On Monday, Cresco Labs stock closed 1.5% higher, lagging behind the nearly 2.4% gain of the S&P 500 index.

 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Cresco Labs Inc. Stock Quote
Cresco Labs Inc.
CRLBF
$3.99 (2.49%) $0.10

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
345%
 
S&P 500 Returns
119%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/16/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.